ACHC Acadia Healthcare Company Inc.

Acadia Healthcare Acquires Three Comprehensive Treatment Centers in North Carolina

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has recently completed the acquisitions of three comprehensive treatment centers (“CTC”) in North Carolina.

Two of the locations, rebranded as Raleigh Comprehensive Treatment Center and Greenville Comprehensive Treatment Center, are located in Raleigh, North Carolina, and Greenville, North Carolina, respectively. The third acquired location, rebranded as Hillsborough Comprehensive Treatment Center, in Hillsborough, North Carolina, serves residents in communities from Durham to Burlington.

With these additions, Acadia now operates 10 CTC locations in North Carolina and 160 locations in 32 states across the country.

“These acquisitions build upon our existing and strong clinical foundation within the state of North Carolina,” said Chris Hunter, chief executive officer of Acadia Healthcare. “The facilities are fully operational with strong track records of positive patient outcomes. The combination of medication-assisted treatment with behavioral therapy and other support services provided at these and other CTC locations can change the course of people’s lives.”

Acadia maintains a partnership with the University of North Carolina’s Center for the Business of Health (CBOH) at UNC Kenan-Flagler Business School, as well as UNC’s School of Nursing and additional undergraduate programs. Acadia and UNC are partnering to develop innovative community-based strategies to improve access to care and mitigate the devastating effects of the opioid epidemic in North Carolina. As part of this collaboration, UNC CBOH and Acadia conducted an analysis of treatment gaps across the state resulting in these markets being identified for CTC expansion.

Hunter continued, “North Carolina is a focus for Acadia to expand capacity and add additional sites of care given the state’s immense need and progressive approach to behavioral healthcare treatment programs.”

Acadia’s CTC medication-assisted treatment (MAT) programs combine behavioral therapy and medication to treat opioid use disorders. Each CTC provides a range of comprehensive substance abuse treatment support services that include medical, counseling, vocational, educational and other treatment services to help patients progress. Behavioral therapies are delivered in an array of treatment models that may include individual and group therapy, intensive outpatient, outpatient, partial hospitalization/day treatment, road to recovery and other programs.

Please visit for more information.

About Acadia Healthcare

Acadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2023, Acadia operated a network of 253 behavioral healthcare facilities with approximately 11,200 beds in 38 states and Puerto Rico. With approximately 23,500 employees serving more than 75,000 patients daily, Acadia is the largest stand-alone behavioral healthcare company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

EN
28/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Acadia Healthcare Company Inc.

 PRESS RELEASE

Acadia Healthcare Announces Pricing of $550 Million Senior Notes Due 2...

FRANKLIN, Tenn.--(BUSINESS WIRE)-- Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today the pricing of its private offering (the “Offering”) of $550 million in aggregate principal amount of 7.375% senior notes due 2033 (the “Notes”), which represents an increase of $50 million in aggregate principal amount from its previous announcement. The Offering is expected to close on March 10, 2025. The closing of the Offering is subject to the satisfaction of customary closing and market conditions. The Company intends to use the proceeds from the Offering to prep...

Moody's Ratings assigns a Ba3 to Acadia's new senior unsecured notes

Moody's Ratings (Moody's) assigned a Ba3 rating to Acadia Healthcare Company, Inc.'s ("Acadia") proposed $500 million senior unsecured notes. There are no changes to the company's existing Ba2 Corporate Family Rating (CFR), Ba2-PD Probability of Default Rating, and Ba3 senior unsecured ratings. The ...

 PRESS RELEASE

Acadia Healthcare Announces Launch of $500 Million Senior Notes Offeri...

FRANKLIN, Tenn.--(BUSINESS WIRE)-- Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today that it has launched a private offering (the “Offering”) of $500 million in aggregate principal amount of senior notes due 2033 (the “Notes”), subject to market conditions and other considerations. The Company intends to use the proceeds from the Offering to prepay a portion of the outstanding borrowings under its existing senior secured revolving line of credit. The Notes have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), an...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Acadia Healthcare Company, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 26 February 2025 in which we reassessed the appropriateness of the ratings ...

 PRESS RELEASE

Acadia Healthcare Reports Fourth Quarter 2024 Results

FRANKLIN, Tenn.--(BUSINESS WIRE)-- Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenue totaled $774.2 million, an increase of 4.2% over the fourth quarter of 2023. Same facility revenue increased 4.7% compared with the fourth quarter of 2023, including an increase in patient days of 3.2% and an increase in revenue per patient day of 1.4%. Net income attributable to Acadia totaled $32.6 million, or $0.35 per diluted share. Adjuste...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch